[1] |
GBD 2016 DALYs and HALE Collaborators.Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J].Lancet, 2017, 390(10100): 1260-1344.
|
[2] |
Milano W, Ambrosio P, Carizzone F, et al.depression and obesity:analysis of common biomarkers [J].Diseases, 2020, 8(2): 23.
|
[3] |
Rosas LG, Xiao L, Lv N, et al.Understanding mechanisms of integrated behavioral therapy for co-occurring obesity and depression in primary care: a mediation analysis in the RAINBOW trial [J].Transl Behav Med, 2021, 11(2): 382-392.
|
[4] |
Lores T, Musker M, Collins K, et al.Pilot trial of a group cognitive behavioural therapy program for comorbid depression and obesity [J].BMC Psychol, 2020, 8(1): 34.
|
[5] |
Borgland SL.Can treatment of obesity reduce depression or vice versa? [J].J Psychiatry Neurosci, 2021, 46(2): E313-E318.
|
[6] |
Murton LM, Plank LD, Cutfield R, et al.Bariatric Surgery and psychological health: a randomised clinical trial in patients with obesity and type 2 diabetes [J].Obes Surg, 2023, 33(5): 1536-1544.
|
[7] |
Moreira FP, Jansen K, Cardoso TA, et al.Metabolic syndrome,depression and anhedonia among young adults [J].Psychiatry Res,2019, 271: 306-310.
|
[8] |
LIhua M, Tao Z, Hongbin M, et al.Metabolic syndrome risk in relation to posttraumatic stress disorder among trauma-exposed civilians in Gansu Province, China [J].Medicine (Baltimore), 2020,99(1): e18614.
|
[9] |
Villarreal-Zegarra D, Bernabe-Ortiz A.Association between arterial hypertension and depressive symptoms: Results from populationbased surveys in Peru [J].Asia Pac Psychiatry, 2020, 12(2): e12385.
|
[10] |
Rotter I, Wiatrak A, Rył A, et al.The relationship between the concentration of magnesium and the presence of depressive symptoms and selected metabolic disorders among men over 50 years of age [J].Life (Basel), 2021, 11(3): 196.
|
[11] |
Xu L, Wang K, Wang S, et al.Sex differences in the association between serum lipids and depressive symptoms: A longitudinal population-based study [J].J Affect Disord, 2021, 291: 154-162.
|
[12] |
Hitij JB.Association of depressive symptoms and hypertension prevalence, awareness, treatment [J].J Hypertens, 2022, 40(9): 1655-1657.
|
[13] |
Qiu W, Cai X, Zheng C, et al.Update on the Relationship Between Depression and Neuroendocrine Metabolism [J].Front Neurosci,2021, 15: 728810.
|
[14] |
Ji S, Chen Y, Zhou Y, et al.Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis [J].Front Psychiatry, 2023, 14: 1118836.
|
[15] |
de Wit L, Luppino F, van Straten A, et al.Depression and obesity: a meta-analysis of community-based studies [J].Psychiatry Res, 2010,178(2): 230-235.
|
[16] |
Plackett B.The vicious cycle of depression and obesity [J].Nature,2022, 608(7924): S42-S43.
|
[17] |
Choy WC, López-León S, Aulchenko YS, et al.Role of shared genetic and environmental factors in symptoms of depression and body composition [J].Psychiatr Genet, 2009, 19(1): 32-38.
|
[18] |
Habib S, Sangaraju SL, Yepez D, et al.The nexus between diabetes and depression: A Narrative Review [J].Cureus, 2022, 14(6): e25611.
|
[19] |
Preiss K, Brennan L, Clarke D.A systematic review of variables associated with the relationship between obesity and depression [J].Obes Rev, 2013, 14(11): 906-918.
|
[20] |
Syeda JN, Rutkofsky IH, Muhammad AS, et al.The psycho-cardiac coupling, myocardial remodeling, and neuroendocrine factor levels:The psychosomatics of major depressive disorder [J].Cureus, 2018,10(4): e2464.
|
[21] |
Milano W, Ambrosio P, Carizzone F, et al.Depression and obesity:analysis of common biomarkers [J].Diseases, 2020, 8(2): 23.
|
[22] |
Ye Z, Zhu L, Li XJ, et al.PC6 electroacupuncture reduces stressinduced autonomic and neuroendocrine responses in rats [J].Heliyon,2023, 9(4): e15291.
|
[23] |
Vignjević PS, Milošević MS, Marković D, et al.Interplay between stress and cancer—A focus on inflammation [J].Front Physiol, 2023,14: 1119095.
|
[24] |
Guo H, Zheng L, Xu H, et al.neurobiological links between stress,brain injury, and disease [J].Oxid Med Cell Longev, 2022, 2022:8111022.
|
[25] |
Zeyen L, Seternes OM, Mikkola I.Crosstalk between p38 MAPK and GR Signaling [J].Int J Mol Sci, 2022, 23(6): 3322.
|
[26] |
Soczynska JK, Kennedy SH, Woldeyohannes HO, et al.Mood disorders and obesity: understanding inflammation as a pathophysiological nexus [J].Neuromolecular Med, 2011, 13(2): 93-116.
|
[27] |
Taylor VH, Macqueen GM.The role of adipokines in understanding the associations between obesity and depression [J].J Obes, 2010,2010: 748048.
|
[28] |
Ugur M, Kanit L, Koylu EO, et al.Cocaine- and amphetamineregulated transcript promoter regulated by nicotine in nerve growth factor-treated PC12 cells [J].Physiol Int, 2019, 106(3): 272-282.
|
[29] |
Scheen A.Obesity, type 2 diabetes, metabolic syndrome and depression: a two-way relationship [J].Rev Med Liege, 2023, 78(4):199-203.
|
[30] |
Afari N, Noonan C, Goldberg J, et al.Depression and obesity: do shared genes explain the relationship? [J].Depress Anxiety, 2010,27(9): 799-806.
|
[31] |
Jokela M, Elovainio M, Keltikangas-Järvinen L, et al.Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score [J].Genes Brain Behav, 2012, 11(8): 942-948.
|
[32] |
Han S, Cui Q, Wang X, et al.Resting state functional network switching rate is differently altered in bipolar disorder and major depressive disorder [J].Hum Brain Mapp, 2020, 41(12): 3295-3304.
|
[33] |
Sahafnejad Z, Ramazi S, Allahverdi A.An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review [J].Genes (Basel), 2023, 14(4): 873.
|
[34] |
Panariello F, Fanelli G, Fabbri C, et al.Epigenetic basis of psychiatric disorders: A narrative review [J].CNS Neurol Disord Drug Targets,2022, 21(4): 302-315.
|
[35] |
Gharipour M, Barekatain M, Sung J, et al.the epigenetic overlap between obesity and mood disorders: A systematic review [J].Int J Mol Sci, 2020, 21(18): 6758.
|
[36] |
Bray GA.Obesity: a 100 year perspective [J].Int J Obes (Lond),Published online May 7, 2024.
|
[37] |
Nogrady B.Habit-linked brain circuits light up in people with eating disorders [J].Nature, Published online April 4, 2023.
|
[38] |
van Dijk SJ, Molloy PL, Varinli H, et al.Epigenetics and human obesity [J].Int J Obes (Lond), 2015, 39(1): 85-97.
|
[39] |
El Ghoch M, Calugi S, Dalle Grave R.The effects of lowcarbohydrate diets on psychosocial outcomes in obesity/overweight:a systematic review of randomized, controlled studies [J].Nutrients,2016, 8(7): 402-402.
|
[40] |
Fabricatore AN, Wadden TA, Higginbotham AJ, et al.Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis [J].Int J Obes (Lond), 2011, 35(11): 1363-1376.
|
[41] |
Grilo CM, White MA.Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as [J].Behav Res Ther, 2013, 51(3): 167-175.
|
[42] |
Weghuber D, Barrett T, Barrientos-Pérez M, et al.Once-weekly semaglutide in adolescents with obesity [J].N Engl J Med, 2022,387(24): 2245-2257.
|
[43] |
Ben Othman R, Ben Amor N, Mahjoub F, et al.A clinical trial about effects of prebiotic and probiotic supplementation on weight loss,psychological profile and metabolic parameters in obese subjects [J].Endocrinol Diabetes Metab, 2023, 6(2): e402.
|
[44] |
CourcoulasAP, Gallagher JW, Neiberg RH, et al.Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial [J].Journal Of Clinical Endocrinology &Metabolism, 2020, 105(3): 866-876.
|
[45] |
Kotackova L, Marecek R, Mouraviev A, et al.Bariatric surgery and its impact on depressive symptoms, cognition, brain and inflammation[J].Front Endocrinol (Lausanne), 2023, 14: 1171244.
|
[46] |
Aylward L, Lilly C, Konsor M, et al.How soon do depression and anxiety symptoms improve after bariatric surgery? [J].Healthcare(Basel), 2023, 11(6): 862-862.
|